{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:02:04Z","timestamp":1790305324415,"version":"4.1.0"},"reference-count":29,"publisher":"Bioscientifica","issue":"12","content-domain":{"domain":["erc.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,1]]},"abstract":"<jats:p>\n                    The objective of our study was to determine the prevalence of glycemic disorders (diabetes mellitus and prediabetes) in patients with pheochromocytomas and sympathetic paragangliomas (PPGLs) and identify risk factors for their development and the likelihood of their resolution after surgery. A multicentric retrospective study of patients with PPGLs submitted to surgery between 2000 and 2021 in 17 Spanish hospitals was performed. Diabetes-specific data were collected at diagnosis, in the immediate- and long-term postsurgical follow-up. A total of 229 patients with PPGLs were included (218 with pheochromocytomas and 11 with sympathetic paragangliomas). Before surgery, glycemic disorders were diagnosed in 35.4% of the patients (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200981): 54 with diabetes and 27 with prediabetes. The variables independently associated with a higher risk of glycemic disorders were sporadic PPGL (odds ratio (OR)\u2009=\u20093.26 (1.14\u20139.36)) and hypertension (OR\u2009=\u20093.14 (1.09\u20139.01)). A significant decrease in fasting plasma glucose and HbA1c levels was observed after surgery, in the short-term and long-term follow-up (\n                    <jats:italic>P<\/jats:italic>\n                    &lt; 0.001). After a median follow-up of 48.5 months (range 3.3\u2013168.9), after surgery, 52% of diabetic and 68% of prediabetic patients experienced a complete resolution. Lower body mass index (BMI) (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.001), lower glucose levels (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.047) and shorter duration of diabetes prior to surgery (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.021) were associated with a higher probability of diabetes resolution. In conclusion, glycemic disorders in patients with PPGLs are present in more than a third of them at diagnosis. Sporadic PPGLs and hypertension are risk factors for their development. More than 50% of cases experience a complete resolution of the glycemic disorder after resection of the PPGLs.\n                  <\/jats:p>","DOI":"10.1530\/erc-22-0218","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T11:33:23Z","timestamp":1662550403000},"page":"645-655","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":16,"title":["Glycemic disorders in patients with pheochromocytomas and sympathetic paragangliomas"],"prefix":"10.1530","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0519-0072","authenticated-orcid":true,"given":"Marta","family":"Araujo-Castro","sequence":"first","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario Ram\u00f3n y Cajal, Madrid, Spain"},{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica Ram\u00f3n y Cajal (IRYCIS), Madrid, Spain"},{"name":"University of Alcal\u00e1, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"M\u00ednguez Ojeda","sequence":"additional","affiliation":[{"name":"Urology Department, Hospital Universitario Ram\u00f3n y Cajal, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogelio","family":"Garc\u00eda Centeno","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Carmen","family":"L\u00f3pez-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario de Albacete, Albacete, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Lamas","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario de Albacete, Albacete, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia Alexandra","family":"Hanzu","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Clinic, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Mora","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Clinic, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"del Castillo Tous","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario Virgen de la Macarena, Sevilla, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0951-5428","authenticated-orcid":true,"given":"Pablo","family":"Rodr\u00edguez de Vera G\u00f3mez","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario Virgen de la Macarena, Sevilla, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0310-7095","authenticated-orcid":true,"given":"Paola","family":"Parra Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario La Paz Madrid, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4448-7941","authenticated-orcid":true,"given":"Cristina","family":"Alvarez-Escola","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario La Paz Madrid, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepci\u00f3n","family":"Blanco Carrera","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario Pr\u00edncipe de Asturias, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Barahona San Mill\u00e1n","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Institut Catal\u00e0 de la Salut Girona, Girona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Recasens","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Institut Catal\u00e0 de la Salut Girona, Girona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Vald\u00e9s","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario de Cabue\u00f1es, Asturias, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Gracia Gimeno","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Royo Villanova, Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paz","family":"de Miguel Novoa","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Cl\u00ednico San Carlos, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"Vicente","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario de Toledo, Toledo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9734-4824","authenticated-orcid":true,"given":"Laura","family":"Manj\u00f3n","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario Central de Asturias, Oviedo, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria del Principado de Asturias (ISPA)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1igo","family":"Garc\u00eda Sanz","sequence":"additional","affiliation":[{"name":"General & Digestive Surgery Department, Hospital Universitario de La Princesa, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Michalopoulou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Nutrition, Joan XXIII University Hospital, Tarragona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6737-7289","authenticated-orcid":true,"given":"Mar\u00eda","family":"Calatayud","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario Doce de Octubre, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Endocrine Journal","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1507\/endocrj.EJ18-0407","article-title":"Differences in the actions of adrenaline and noradrenaline with regard to glucose intolerance in patients with pheochromocytoma","volume":"66","author":"Abe","year":"2019","unstructured":"Abe IFujii HOhishi HSugimoto KMinezaki MNakagawa MTakahara SKudo TAbe MOhe K2019Differences in the actions of adrenaline and noradrenaline with regard to glucose intolerance in patients with pheochromocytoma. Endocrine Journal66187\u2013192. (https:\/\/doi.org\/10.1507\/endocrj.EJ18-0407)10.1507\/endocrj.EJ18-0407"},{"key":"bib2","series-title":"World Journal of Surgery","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/BF01658514","article-title":"Hypoglycemia induced by excessive rebound secretion of insulin after removal of pheochromocytoma","volume":"14","author":"Akiba","year":"1990","unstructured":"Akiba MKodama TIto YObara TFujimoto Y1990Hypoglycemia induced by excessive rebound secretion of insulin after removal of pheochromocytoma. World Journal of Surgery14317\u2013324. (https:\/\/doi.org\/10.1007\/BF01658514)10.1007\/BF01658514"},{"issue":"Supplement 1","key":"bib3","series-title":"Diabetes Care","first-page":"S17","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022","volume":"45","year":"2022","unstructured":"American Diabetes Association Professional Practice Committee20222. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care45 (Supplement 1) S17\u2013S38. (https:\/\/doi.org\/10.2337\/dc22-S002)"},{"key":"bib4","series-title":"International Journal of Urology","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/iju.13864","article-title":"Incidence and predictive factors of hypoglycemia after pheochromocytoma resection","volume":"26","author":"Araki","year":"2019","unstructured":"Araki SKijima TWaseda YKomai YNakanishi YUehara SYasuda YYoshida SYokoyama MIshioka J2019Incidence and predictive factors of hypoglycemia after pheochromocytoma resection. International Journal of Urology26273\u2013277. (https:\/\/doi.org\/10.1111\/IJU.13864)10.1111\/iju.13864"},{"key":"bib5","series-title":"Endocrine-Related Cancer","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1530\/ERC-21-0230","article-title":"Risk factors for intraoperative complications in pheochromocytomas","volume":"28","author":"Araujo-Castro","year":"2021a","unstructured":"Araujo-Castro MGarcia Centeno RL\u00f3pez-Garc\u00eda MCLamas C\u00c1lvarez-Escol\u00e1 CCalatayud Guti\u00e9rrez MBlanco-Carrera Cde Miguel Novoa PVald\u00e9s NGracia Gimeno P2021aRisk factors for intraoperative complications in pheochromocytomas. Endocrine-Related Cancer28695\u2013703. (https:\/\/doi.org\/10.1530\/ERC-21-0230)10.1530\/ERC-21-0230"},{"key":"bib6","series-title":"Endocrine","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s12020-021-02843-6","article-title":"Surgical outcomes in the pheochromocytoma surgery. Results from the PHEO-RISK STUDY","volume":"74","author":"Araujo-Castro","year":"2021b","unstructured":"Araujo-Castro MGarc\u00eda Centero RL\u00f3pez-Garc\u00eda MC\u00c1lvarez Escol\u00e1 CCalatayud Guti\u00e9rrez MBlanco Carrera CDe Miguel Novoa PVald\u00e9s Gallego NHanzu FAGracia Gimeno P2021bSurgical outcomes in the pheochromocytoma surgery. Results from the PHEO-RISK STUDY. Endocrine74676\u2013684. (https:\/\/doi.org\/10.1007\/s12020-021-02843-6)10.1007\/s12020-021-02843-6"},{"key":"bib7","series-title":"Clinical and Experimental Medicine","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10238-021-00763-3","article-title":"Special situations in pheochromocytomas and paragangliomas: pregnancy, metastatic disease, and cyanotic congenital heart diseases","volume":"22","author":"Araujo-Castro","year":"2022","unstructured":"Araujo-Castro MNattero Chavez LMart\u00ednez Lorca AMolina-Cerrillo JAlonso-Gordoa TPascual-Corrales E2022Special situations in pheochromocytomas and paragangliomas: pregnancy, metastatic disease, and cyanotic congenital heart diseases. Clinical and Experimental Medicine22359\u2013370. (https:\/\/doi.org\/10.1007\/S10238-021-00763-3)10.1007\/s10238-021-00763-3"},{"key":"bib8","series-title":"Annals of Surgical Oncology","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1245\/s10434-016-5701-6","article-title":"Resection of pheochromocytoma improves diabetes mellitus in the majority of patients","volume":"24","author":"Beninato","year":"2017","unstructured":"Beninato TKluijfhout WPDrake FTLim JKwon JSXiong MShen WTGosnell JELiu CSuh I2017Resection of pheochromocytoma improves diabetes mellitus in the majority of patients. Annals of Surgical Oncology241208\u20131213. (https:\/\/doi.org\/10.1245\/S10434-016-5701-6)10.1245\/s10434-016-5701-6"},{"key":"bib9","series-title":"Diabetes Care","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.2337\/dc09-9036","article-title":"How do we define cure of diabetes?","volume":"32","author":"Buse","year":"2009","unstructured":"Buse JBCaprio SCefalu WTCeriello ADel Prato SInzucchi SEMcLaughlin SPhillips GLRobertson RPRubino F2009How do we define cure of diabetes?Diabetes Care322133\u20132135. (https:\/\/doi.org\/10.2337\/DC09-9036)10.2337\/dc09-9036"},{"key":"bib10","series-title":"Annals of African Medicine","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4103\/aam.aam_13_20","article-title":"Pheochromocytoma and glucoregulation disorders","volume":"20","author":"Derrou","year":"2021","unstructured":"Derrou SBouziane TSalhi HEl Ouahabi H2021Pheochromocytoma and glucoregulation disorders. Annals of African Medicine2042\u201345. (https:\/\/doi.org\/10.4103\/aam.aam_13_20)10.4103\/aam.aam_13_20"},{"key":"bib11","series-title":"Clinical Chemistry","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1373\/clinchem.2010.153320","article-title":"Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma","volume":"57","author":"Eisenhofer","year":"2011","unstructured":"Eisenhofer GLenders JWMTimmers HMannelli MGrebe SKHofbauer LCBornstein SRTiebel OAdams KBratslavsky G2011Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clinical Chemistry57411\u2013420. (https:\/\/doi.org\/10.1373\/CLINCHEM.2010.153320)10.1373\/clinchem.2010.153320"},{"key":"bib12","series-title":"Annales d\u2019Endocrinologie","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ando.2020.01.001","article-title":"Prevalence and progression of carbohydrate disorders in patients with pheochromocytoma\/paraganglioma: retrospective single-center study","volume":"81","author":"Elenkova","year":"2020","unstructured":"Elenkova AMatrozova JVasilev VRobeva RZacharieva S2020Prevalence and progression of carbohydrate disorders in patients with pheochromocytoma\/paraganglioma: retrospective single-center study. Annales d\u2019Endocrinologie813\u201310. (https:\/\/doi.org\/10.1016\/J.ANDO.2020.01.001)10.1016\/j.ando.2020.01.001"},{"key":"bib13","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1210\/jcem-49-3-322","article-title":"Pancreatic alpha- and beta-cell function in pheochromocytoma","volume":"49","author":"Hamaji","year":"1979","unstructured":"Hamaji M1979Pancreatic alpha- and beta-cell function in pheochromocytoma. Journal of Clinical Endocrinology and Metabolism49322\u2013325. (https:\/\/doi.org\/10.1210\/JCEM-49-3-322)10.1210\/jcem-49-3-322"},{"key":"bib14","series-title":"Journal of Biomedical Informatics","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap) \u2013 a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","unstructured":"Harris PATaylor RThielke RPayne JGonzalez NConde JG2009Research electronic data capture (REDCap) \u2013 a metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics42377\u2013381. (https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010)10.1016\/j.jbi.2008.08.010"},{"key":"bib15","series-title":"Journal of Biomedical Informatics","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","unstructured":"Harris PATaylor RMinor BLElliott VFernandez MO\u2019Neal LMcLeod LDelacqua GDelacqua FKirby J2019The REDCap consortium: building an international community of software platform partners. Journal of Biomedical Informatics95103208. (https:\/\/doi.org\/10.1016\/j.jbi.2019.103208)10.1016\/j.jbi.2019.103208"},{"key":"bib16","series-title":"Diabetes and Metabolic Syndrome","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/j.dsx.2020.10.030","article-title":"Diabetes mellitus in pheochromocytoma and paraganglioma: prevalence, dynamics of insulin secretion\/sensitivity and predictors of remission","volume":"14","author":"Khatiwada","year":"2020","unstructured":"Khatiwada SAgarwal SKandasamy DJyotsna VPKumar RKumar Bansal VPandey RMGupta NTandon N2020Diabetes mellitus in pheochromocytoma and paraganglioma: prevalence, dynamics of insulin secretion\/sensitivity and predictors of remission. Diabetes and Metabolic Syndrome142169\u20132175. (https:\/\/doi.org\/10.1016\/J.DSX.2020.10.030)10.1016\/j.dsx.2020.10.030"},{"key":"bib17","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"e4028","DOI":"10.1210\/clinem\/dgab401","article-title":"Correlation between plasma catecholamines, weight, and diabetes in pheochromocytoma and paraganglioma","volume":"106","author":"Krumeich","year":"2021","unstructured":"Krumeich LNCucchiara AJNathanson KLKelz RRFishbein LFraker DLRoses RECohen DLWachtel H2021Correlation between plasma catecholamines, weight, and diabetes in pheochromocytoma and paraganglioma. Journal of Clinical Endocrinology and Metabolism106e4028\u2013e4038. (https:\/\/doi.org\/10.1210\/CLINEM\/DGAB401)10.1210\/clinem\/dgab401"},{"key":"bib18","series-title":"Journal of Hypertension","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1097\/00004872-200309000-00020","article-title":"Diabetes as a marker of pheochromocytoma in hypertensive patients","volume":"21","author":"La Batide-Alanore","year":"2003","unstructured":"La Batide-Alanore AChatellier GPlouin PF2003Diabetes as a marker of pheochromocytoma in hypertensive patients. Journal of Hypertension211703\u20131707. (https:\/\/doi.org\/10.1097\/00004872-200309000-00020)10.1097\/00004872-200309000-00020"},{"key":"bib19","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","author":"Lenders","year":"2005","unstructured":"Lenders JWMEisenhofer GMannelli MPacak K2005Phaeochromocytoma. Lancet366665\u2013675. (https:\/\/doi.org\/10.1016\/S0140-6736(0567139-5)10.1016\/S0140-6736(05)67139-5"},{"key":"bib20","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","unstructured":"Lenders JWMDuh QYEisenhofer GGimenez-Roqueplo APGrebe SKGMurad MHNaruse MPacak KYoung WF & Endocrine Society2014Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism991915\u20131942. (https:\/\/doi.org\/10.1210\/jc.2014-1498)10.1210\/jc.2014-1498"},{"key":"bib21","series-title":"Asian Journal of Surgery","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.asjsur.2019.01.012","article-title":"Will the resection of pheochromocytoma improve preoperative diabetes mellitus?","volume":"42","author":"Liu","year":"2019","unstructured":"Liu ZHZhou LLin De LDChen TJiang QYLiu ZHWang KJZhu YCLi HRen Y2019Will the resection of pheochromocytoma improve preoperative diabetes mellitus?Asian Journal of Surgery42990\u2013994. (https:\/\/doi.org\/10.1016\/J.ASJSUR.2019.01.012)10.1016\/j.asjsur.2019.01.012"},{"key":"bib22","series-title":"Endocrine Practice","doi-asserted-by":"publisher","first-page":"999","DOI":"10.4158\/EP171914.RA","article-title":"The physiology behind diabetes mellitus in patients with pheochromocytoma: a review of the literature","volume":"23","author":"Mesmar","year":"2017","unstructured":"Mesmar BPoola-Kella SMalek R2017The physiology behind diabetes mellitus in patients with pheochromocytoma: a review of the literature. Endocrine Practice23999\u20131005. (https:\/\/doi.org\/10.4158\/EP171914.RA)10.4158\/EP171914.RA"},{"key":"bib23","series-title":"Metabolism: Clinical and Experimental","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.metabol.2015.03.004","article-title":"Changes in visceral and subcutaneous fat mass in patients with pheochromocytoma","volume":"64","author":"Okamura","year":"2015","unstructured":"Okamura TNakajima YSatoh THashimoto KSapkota SYamada EOkada SFukuda JHiguchi TTsushima Y2015Changes in visceral and subcutaneous fat mass in patients with pheochromocytoma. Metabolism: Clinical and Experimental64706\u2013712. (https:\/\/doi.org\/10.1016\/J.METABOL.2015.03.004)10.1016\/j.metabol.2015.03.004"},{"key":"bib24","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1210\/jc.2012-3625","article-title":"Changes in energy metabolism in pheochromocytoma","volume":"98","author":"Petr\u00e1k","year":"2013","unstructured":"Petr\u00e1k OHaluz\u00edkov\u00e1 DKav\u00e1lkov\u00e1 P\u0160trauch BRosa JHolaj RVr\u00e1nkov\u00e1 ABMichalsky DHaluz\u00edk MZelinka T2013Changes in energy metabolism in pheochromocytoma. Journal of Clinical Endocrinology and Metabolism981651\u20131658. (https:\/\/doi.org\/10.1210\/JC.2012-3625)10.1210\/jc.2012-3625"},{"key":"bib25","series-title":"Central European Journal of Urology","first-page":"361","article-title":"The effect of surgical treatment of phaeochromocytoma on concomitant arterial hypertension and diabetes mellitus in a single-centre retrospective study","volume":"67","author":"Pogorzelski","year":"2014","unstructured":"Pogorzelski RToutounchi SKrajewska EFiszer P\u0141ykowski MZapa\u0142a \u0141Szostek MJakuczun WPachucki JSk\u00f3rski M2014The effect of surgical treatment of phaeochromocytoma on concomitant arterial hypertension and diabetes mellitus in a single-centre retrospective study. Central European Journal of Urology67361\u2013365. (https:\/\/doi.org\/10.5173\/CEJU.2014.04.ART9)"},{"key":"bib26","series-title":"Hormone and Metabolic Research","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1055\/s-0042-124189","article-title":"Changes in body mass index in pheochromocytoma patients following adrenalectomy","volume":"49","author":"Spyroglou","year":"2017","unstructured":"Spyroglou AAdolf CHahner SQuinkler MLadurner RReincke MBeuschlein F2017Changes in body mass index in pheochromocytoma patients following adrenalectomy. Hormone and Metabolic Research49208\u2013213. (https:\/\/doi.org\/10.1055\/S-0042-124189)10.1055\/s-0042-124189"},{"key":"bib27","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1210\/jc.2003-030000","article-title":"Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma","volume":"88","author":"Wiesner","year":"2003","unstructured":"Wiesner TDBl\u00fcher MWindgassen MPaschke R2003Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma. Journal of Clinical Endocrinology and Metabolism883632\u20133636. (https:\/\/doi.org\/10.1210\/jc.2003-030000)10.1210\/jc.2003-030000"},{"key":"bib28","series-title":"Lancet","article-title":"Inhibition of insulin secretion by a phaeochromocytoma","volume":"2","author":"Wilber","year":"1966","unstructured":"Wilber JFTurtle JRCrane NA1966Inhibition of insulin secretion by a phaeochromocytoma. Lancet2 733. (https:\/\/doi.org\/10.1016\/S0140-6736(6692986-2)"},{"key":"bib29","series-title":"BMC Cardiovascular Disorders","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12872-021-02013-6","article-title":"Acute cardiac complications and subclinical myocardial injuries associated with pheochromocytoma and paraganglioma","volume":"21","author":"Zhou","year":"2021","unstructured":"Zhou JXuan HMiao YHu JDai Y2021Acute cardiac complications and subclinical myocardial injuries associated with pheochromocytoma and paraganglioma. BMC Cardiovascular Disorders21203. (https:\/\/doi.org\/10.1186\/s12872-021-02013-6)10.1186\/s12872-021-02013-6"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/29\/12\/ERC-22-0218.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/erc.bioscientifica.com\/downloadpdf\/journals\/erc\/29\/12\/ERC-22-0218.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/erc.bioscientifica.com\/downloadpdf\/journals\/erc\/29\/12\/ERC-22-0218.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:56:21Z","timestamp":1784555781000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/erc\/article\/29\/12\/645-655\/25587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":29,"journal-issue":{"issue":"12"},"URL":"https:\/\/doi.org\/10.1530\/erc-22-0218","relation":{},"ISSN":["1351-0088","1479-6821"],"issn-type":[{"value":"1351-0088","type":"print"},{"value":"1479-6821","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]}}}